Kannourakis G - Search Results

1

Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion.

Stuart SF, Curpen P, Gomes AJ, Lan MC, Nie S, Williamson NA, Kannourakis G, Morokoff AP, Achuthan AA, Luwor RB. Stuart SF, et al. Among authors: kannourakis g. Brain Sci. 2024 Jan 17;14(1):89. doi: 10.3390/brainsci14010089. Brain Sci. 2024. PMID: 38248304 Free PMC article.

2

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.

Leung D, Price ZK, Lokman NA, Wang W, Goonetilleke L, Kadife E, Oehler MK, Ricciardelli C, Kannourakis G, Ahmed N. Leung D, et al. Among authors: kannourakis g. J Transl Med. 2022 Dec 3;20(1):556. doi: 10.1186/s12967-022-03776-y. J Transl Med. 2022. PMID: 36463238 Free PMC article.

3

In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.

Sharma R, Balta S, Raza A, Escalona RM, Kannourakis G, Prithviraj P, Ahmed N. Sharma R, et al. Among authors: kannourakis g. Cancers (Basel). 2023 May 1;15(9):2586. doi: 10.3390/cancers15092586. Cancers (Basel). 2023. PMID: 37174052 Free PMC article.

4

The role of pregnancy associated plasma protein-A in triple negative breast cancer: a promising target for achieving clinical benefits.

Poddar A, Ahmady F, Rao SR, Sharma R, Kannourakis G, Prithviraj P, Jayachandran A. Poddar A, et al. Among authors: kannourakis g. J Biomed Sci. 2024 Feb 23;31(1):23. doi: 10.1186/s12929-024-01012-x. J Biomed Sci. 2024. PMID: 38395880 Free PMC article. Review.

5

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

Escalona RM, Chu S, Kadife E, Kelly JK, Kannourakis G, Findlay JK, Ahmed N. Escalona RM, et al. Among authors: kannourakis g. Cancer Cell Int. 2022 Dec 30;22(1):422. doi: 10.1186/s12935-022-02838-x. Cancer Cell Int. 2022. PMID: 36585738 Free PMC article.

6

Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer.

Poddar A, Rao SR, Prithviraj P, Kannourakis G, Jayachandran A. Poddar A, et al. Among authors: kannourakis g. Curr Oncol. 2022 Sep 23;29(10):6847-6863. doi: 10.3390/curroncol29100540. Curr Oncol. 2022. PMID: 36290817 Free PMC article. Review.

7

Divergent molecular networks program functionally distinct CD8⁺ skin-resident memory T cells.

Park SL, Christo SN, Wells AC, Gandolfo LC, Zaid A, Alexandre YO, Burn TN, Schröder J, Collins N, Han SJ, Guillaume SM, Evrard M, Castellucci C, Davies B, Osman M, Obers A, McDonald KM, Wang H, Mueller SN, Kannourakis G, Berzins SP, Mielke LA, Carbone FR, Kallies A, Speed TP, Belkaid Y, Mackay LK. Park SL, et al. Among authors: kannourakis g. Science. 2023 Dec;382(6674):1073-1079. doi: 10.1126/science.adi8885. Epub 2023 Nov 30. Science. 2023. PMID: 38033053

8

A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus.

Perriman L, Tavakolinia N, Jalali S, Li S, Hickey PF, Amann-Zalcenstein D, Ho WWH, Baldwin TM, Piers AT, Konstantinov IE, Anderson J, Stanley EG, Licciardi PV, Kannourakis G, Naik SH, Koay HF, Mackay LK, Berzins SP, Pellicci DG. Perriman L, et al. Among authors: kannourakis g. Sci Immunol. 2023 Jul 21;8(85):eabo4365. doi: 10.1126/sciimmunol.abo4365. Epub 2023 Jul 14. Sci Immunol. 2023. PMID: 37450574

9

Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results.

Ciardiello F, Bang YJ, Cervantes A, Dvorkin M, Lopez CD, Metges JP, Sánchez Ruiz A, Calvo M, Strickland AH, Kannourakis G, Muro K, Kawakami H, Wei J, Borg C, Zhu Z, Gupta N, Pelham RJ, Shen L. Ciardiello F, et al. Among authors: kannourakis g. Cancer Med. 2023 Jun;12(12):13145-13154. doi: 10.1002/cam4.5997. Epub 2023 Jun 1. Cancer Med. 2023. PMID: 37260158 Free PMC article. Clinical Trial.

10

Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.

Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page